Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer. [electronic resource]
Producer: 20170421Description: e0175409 p. digitalISSN:- 1932-6203
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.